Hongkong XinRunde Chemical Co., Ltd

 

Reliable Manufacturer and Supplier of Top Quality Pharmaceutical Raw Material and Pharmaceutical Intermediate

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsAnti Depression Drug

Female Sex Powder Anti Depression Drug Flibanserin Flibanserin Powder Cas 167933-07-5

Female Sex Powder Anti Depression Drug Flibanserin Flibanserin Powder Cas 167933-07-5

Female Sex Powder Anti Depression Drug Flibanserin Flibanserin Powder Cas 167933-07-5
Female Sex Powder Anti Depression Drug Flibanserin Flibanserin Powder Cas 167933-07-5

Large Image :  Female Sex Powder Anti Depression Drug Flibanserin Flibanserin Powder Cas 167933-07-5 Get Best Price

Product Details:

Place of Origin: CHINA
Brand Name: XRD
Certification: GMP
Model Number: 167933-07-5

Payment & Shipping Terms:

Minimum Order Quantity: negotiable
Price: Inquiry for Negotiable
Packaging Details: 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require
Delivery Time: 3-7 work days
Payment Terms: T/T, Western Union,Bitcoin
Supply Ability: 100kg/year
Detailed Product Description
Cas No.: 167933-07-5 Product Name: Flibanserin
Usage: Pharmaceutical Raw Material Appearance: White Powder
Assay: 99% Flibanserin Grade: Pharmaceutical Grade
Storage: Cool Dried Storage Application: Pharmaceutical Raw Intermediates
High Light:

pharmaceutical grade raw materials

,

zopiclone for anxiety

Female Sex Powder Flibanserin Flibanserin powder Cas 167933-07-5

 

Description:
 
Testing Items Specifications Results
Characteristics An off-white to white powder Complied
Identification Meet the requirements Positive
Loss on Drying ≤0.50% 0.13%
Heavy Metals ≤20PPM <20PPM
Purity (by HPLC) ≥99.0% 99.2%
Conclusion: The commodity is complied with the standard of the factory

 

Character:

 

Flibanserin is a new drug being investigated for the prevention of HSDD in woman. HSDD, is a relatively new term developed to describe Hypoactive Sexual Desire Disorder which basically means a woman whose is otherwise healthy has a lacking libido, or a lack of sexual desire. Studies show that about 10-20% of women face this problem and some say HSDD outnumbers men with sexual problems. Flibanserin is classified as a 5-HT serotonin receptor agonist and a dopamine D4 receptor partial agonist. It is a Non-Hormonal agent that in essence increases dopamine and noradrenalin while reducing Serotonin in the brain.

Flibanserin, sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication increases the number of satisfying sexual events per month by about one half over placebo from a starting point of about two to three. The certainty of the estimate is low


Description:

 

Flibanserin is a drug developed to treat hypoactive sexual desire disorder (HSDD) in women. Women with HSDD have a chronic lack of interest in sex that cannot be explained by another medical condition. HSDD is also accompanied by feelings of distress.

More specifically, it is thought that flibanserin corrects an imbalance of levels of these neurotransmitters by increasing dopamine and norepinephrine and decreasing serotonin. In clinical studies, flibanserin was evaluated for its ability to increase the frequency of satisfying sexual events, increase the intensity of sexual desire and decrease the associated distress women feel from its loss.

 

Usage And Dosage:  

 

Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had "satisfying sexual events". In those on flibanserin it rose from 2.8 to 4.5 times a month while women receiving placebo reported also an increase of "satisfying sexual events" from 2.7 to 3.7 times a month. The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.

 

Application:

 

HSDD is the most commonly reported form of female sexual dysfunction. HSDD is defined as a persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty, and which is not better accounted for by a medical, substance-related , psychiatric (e.g., depression) or other sexual condition. The cause of HSDD is believed to involve a multitude of social, psychological and biological factors and may be attributed to a complex interplay of these factors.

Flibanserin is a novel, nonhormonal drug that has been studied in clinical trials for the treatment of HSDD in premenopausal and postmenopausal women. The application submitted to the FDA is for premenopausal women. Flibanserin is believed to work on key neurotransmitters, or chemicals, in the brain that affect sexual desire. More specifically, it is thought that flibanserin corrects an imbalance of levels of these neurotransmitters by increasing dopamine and norepinephrine (both responsible for sexual excitement) and decreasing serotonin (responsible for sexual inhibition). In clinical studies, flibanserin was evaluated for its ability to increase the frequency of satisfying sexual events, increase the intensity of sexual desire and decrease the associated distress women feel from its loss.

 

 
Packing:
 
Female Sex Powder Anti Depression Drug Flibanserin Flibanserin Powder Cas 167933-07-5 0
 
 

Female Sex Powder Flibanserin Flibanserin powder Cas 167933-07-5

 

Contact Details
Hongkong XinRunde Chemical Co., Ltd

Contact Person: bruce

Send your inquiry directly to us